KRT20 anticorps (AA 196-323)

N° du produit ABIN7871724

L’anticorps anti-KRT20 Monoclonal Souris est utilisé pour la détection de KRT20 dans des échantillons de Humain. Il a été validé pour WB et IHC (p).

Aperçu rapide pour KRT20 anticorps (AA 196-323) (ABIN7871724)

Antigène: KRT20 (Keratin 20 (KRT20))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp KRT20 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: KRT20-1991

Détail du produit anti-KRT20 anticorps

Épitope: AA 196-323

Fonction: Cytokeratin 20 Antibody / CK20 / KRT20

Purification: Protein G affinity chromatography

Immunogène: A portion of amino acids 196-323 from the human protein was used as the immunogen for this Cytokeratin 20 antibody.

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal dilution of the Cytokeratin 20 antibody should be determined by the researcher.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store the Cytokeratin 20 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur KRT20

Antigène: KRT20 (Keratin 20 (KRT20))

Autre désignation: Cytokeratin 20

Sujet: This mAb recognizes an intermediate filament protein of 46 kDa, identified as Cytokeratin 20 (KRT20, CK20). KRT is abundantly expressed in goblet cells and enterocytes of the gastrointestinal tract. It is a useful marker of pancreatic and colorectal cancer. KRT20 is expressed under normal, hyperplastic and neoplastic conditions. It has been detected in adenocarcinomas of the colon, stomach and biliary tract. Breast carcinomas are generally non-reactive.

UniProt: P35900